We are live on ! Find out more
RI

Ridgewood Investments Portfolio holdings

AUM $267M
This Fund
S&P 500
This Quarter Est. Return
+11.3%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$141M
AUM Growth
+$20.6M
Cap. Flow
+$8.77M
Cap. Flow %
6.24%
Top 10 Hldgs %
26.04%
Holding
210
New
36
Increased
62
Reduced
65
Closed
12

Top Buys

Rank Stock Value
1
GSK icon
GSK
GSK
+$1.17M
2
D icon
Dominion Energy
D
+$737K
3
PRGO icon
Perrigo
PRGO
+$626K
4
PBR icon
Petrobras
PBR
+$557K
5
STIP icon
iShares 0-5 Year TIPS Bond ETF
STIP
+$534K

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$855K
2
CAH icon
Cardinal Health
CAH
+$830K
3
TSLA icon
Tesla
TSLA
+$418K
4
RBLX icon
Roblox
RBLX
+$408K
5
CTXS
Citrix Systems Inc
CTXS
+$364K

Sector Composition

Rank Sector Weight
1 Financials 26.11%
2 Healthcare 12.72%
3 Technology 7.82%
4 Industrials 7.61%
5 Consumer Discretionary 6.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRI icon
151
Carter's
CRI
$1.47B
$282K 0.2%
3,786
-3
-0.1% -$215
JPM icon
152
JPMorgan Chase
JPM
$950B
$278K 0.2%
2,074
-146
-7% -$18.5K
SRAX
153
DELISTED
SRAX, Inc. Class A Common Stock
SRAX
$278K 0.2%
181,663
+126,843
+231% +$204K
PEP icon
154
PepsiCo
PEP
$190B
$267K 0.19%
1,481
GSY icon
155
Invesco Ultra Short Duration ETF
GSY
$3.88B
$265K 0.19%
5,360
TCBK icon
156
TriCo Bancshares
TCBK
$1.83B
$263K 0.19%
5,152
-1,097
-18% -$57.2K
VRE
157
DELISTED
Veris Residential
VRE
$256K 0.18%
16,084
MINT icon
158
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$17.1B
$251K 0.18%
2,542
L icon
159
Loews
L
$23.6B
$250K 0.18%
4,293
+4
+0.1% +$223
USB icon
160
US Bancorp
USB
$99.6B
$245K 0.17%
5,613
+149
+3% +$6.38K
ADM icon
161
Archer Daniels Midland
ADM
$36.9B
$242K 0.17%
2,610
-541
-17% -$49.9K
NVDA icon
162
NVIDIA
NVDA
$5.42T
$240K 0.17%
+16,390
New +$240K
PGR icon
163
Progressive
PGR
$125B
$238K 0.17%
1,831
DOCU
164
DocuSign
DOCU
$11.5B
$231K 0.16%
4,170
CSX icon
165
CSX Corp
CSX
$93.1B
$228K 0.16%
+7,351
New +$221K
RLI icon
166
RLI Corp
RLI
$5.89B
$222K 0.16%
+3,388
New +$211K
RSSS icon
167
Research Solutions
RSSS
$72.2M
$222K 0.16%
115,537
ABBV icon
168
AbbVie
ABBV
$435B
$219K 0.16%
+1,354
New +$208K
XOM icon
169
ExxonMobil
XOM
$634B
$219K 0.16%
+1,982
New +$212K
TSN icon
170
Tyson Foods
TSN
$20.4B
$219K 0.16%
+3,511
New +$228K
PFE icon
171
Pfizer
PFE
$153B
$217K 0.15%
+4,233
New +$203K
RTX icon
172
RTX Corp
RTX
$301B
$214K 0.15%
+2,118
New +$199K
RPRX icon
173
Royalty Pharma
RPRX
$25.3B
$212K 0.15%
5,370
-302
-5% -$12.6K
TRV icon
174
Travelers Companies
TRV
$80.2B
$209K 0.15%
+1,114
New +$200K
WAT icon
175
Waters Corp
WAT
$39.9B
$208K 0.15%
+606
New +$192K

Similar funds

Ridgewood Investments's Q4 2022 Portfolio in Review

As of Q4 2022, Ridgewood Investments held 210 positions worth $141M, up 17% from $120M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Ridgewood Investments deployed $8.77M of net new capital in Q4 2022, opening 36 new positions and adding to 62 existing holdings. Its largest new stake was GSK: 35,011 shares worth $1.23M.

By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Gilead Sciences, an estimated $855K trimmed.

  • Ridgewood Investments's largest Q4 2022 buy was GSK: 35,011 shares worth $1.23M.
  • Ridgewood Investments added most to Perrigo in Q4 2022, an estimated $626K increase.
  • Ridgewood Investments's biggest Q4 2022 reduction was Gilead Sciences, cutting an estimated $855K.
  • Ridgewood Investments fully exited Tesla in Q4 2022, selling an estimated $418K.
  • Ridgewood Investments's ten largest holdings make up 26% of its $141M portfolio in Q4 2022.
  • Ridgewood Investments opened 36 new positions and closed 12 in Q4 2022.
  • Ridgewood Investments's portfolio value rose 17% quarter-over-quarter to $141M.

Based on Ridgewood Investments's 13F filing for Q4 2022, filed 19 Jan 2023.